ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

38,72
0,43
(1,12%)
Chiuso 05 Luglio 10:00PM
38,75
0,03
(0,08%)
Dopo le ore di negoziazione: 12:16AM

Rigel Pharmaceuticals Inc (RIGL) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-06-22Ms. Kamil Ali JacksonIndependent Director-2,50k87,50kAutomatic Disposition35,0010,13k-19,80%
2026-06-01Mr. Dean L. SchornoExec. VP & CFO-928,0015,92kDerivative Exercise and Sale12,70 - 29,8638,19k-
2026-06-01Mr. Dean L. SchornoExec. VP & CFO2,45k38,35kDerivative Exercise and Retained Stock12,70 - 18,7038,19k6,86%
2026-06-01Mr. David A. SantosExec. VP & Chief Commercial Officer-874,0026,10kSale to Issuer29,8622,07k-3,81%
2026-06-01Mr. Raul R. RodriguezPresident, CEO & Director-2,42k72,38kSale to Issuer29,86181,14k-1,32%
2026-06-01Dr. Lisa RojkjaerInsider-850,0025,38kSale to Issuer29,863,54k-19,37%
2026-06-01Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary-877,0026,19kSale to Issuer29,8612,95k-6,34%
2026-05-26Ms. Kamil Ali JacksonIndependent Director-2,50k72,93kAutomatic Disposition29,1712,63k-16,53%
2026-02-20Dr. Walter H. MoosIndependent Director-4,00k49,44kDerivative Exercise and Sale24,00 - 36,3610,22k-
2026-02-10Dr. Lisa RojkjaerInsider-3,76k130,10kSale to Issuer34,622,81k-57,18%
2026-02-10Mr. Raul R. RodriguezPresident, CEO & Director-7,61k263,35kSale to Issuer34,62179,07k-4,07%
2026-02-10Mr. David A. SantosExec. VP & Chief Commercial Officer-3,55k122,76kSale to Issuer34,6221,33k-14,26%
2026-02-10Mr. Dean L. SchornoExec. VP & CFO-3,55k122,76kSale to Issuer34,6234,02k-9,44%
2026-02-10Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary-3,55k122,76kSale to Issuer34,6212,21k-22,51%
2026-02-02Mr. David A. SantosExec. VP & Chief Commercial Officer-5,72k205,91kSale to Issuer36,0118,30k-23,81%
2026-01-26Mr. Raul R. RodriguezPresident, CEO & Director40,00k1,10MDerivative Exercise and Retained Stock27,40172,58k30,17%
2026-01-26Mr. Raul R. RodriguezPresident, CEO & Director-40,00k379,47kDerivative Exercise and Sale27,40 - 37,00172,58k-
2026-01-26Mr. Raul R. RodriguezPresident, CEO & Director-44,75k1,65MSale to Issuer36,01 - 37,00172,58k-20,59%
2026-02-02Mr. Raymond J. FureyExec. VP, CCO, General Counsel & Corporate Secretary-3,97k142,89kSale to Issuer36,019,18k-30,18%
2026-02-02Mr. Dean L. SchornoExec. VP & CFO-5,49k197,62kSale to Issuer36,0130,99k-15,05%
2025-12-22Mr. Dean L. SchornoExec. VP & CFO6,50k139,79kDerivative Exercise and Retained Stock18,70 - 24,2026,19k33,02%